Physician profile
Sameer Siddiqi
NPI 1417368499
$6,788.23
in general payments reported to CMS, 2019-2025
22 companies · $728 in 2025
The $728 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $505 · 2021: $560 · 2022: $722 · 2023: $952 · 2024: $3,322 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,178 · Travel and Lodging: $1,824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,177.68 |
| Travel and Lodging | $1,824.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,551.73 | 2024-2025 | Evoke |
| Medtronic, INC. | $1,120.59 | 2021-2025 | Intellis Adaptivestim, Adaptix Interbody System With Titan Nanolock Surface Technology, Mazor X System |
| Nevro Corp. | $633.55 | 2020-2024 | Senza |
| Abbott Laboratories | $596.39 | 2020-2024 | Octrode, Proclaim |
| Boston Scientific Corporation | $449.75 | 2020-2025 | Intracept, Intracept Rf Probe |
| Vertos Medical, INC. | $427.88 | 2023-2024 | Mild Device Kit |
| Globus Medical, INC. | $221.36 | 2025 | Senza |
| Relievant Medsystems, INC. | $162.37 | 2023 | Intracept |
| Si-Bone, INC. | $159.22 | 2022 | |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Stryker Corporation | $91.72 | 2025 | Mild Device Kit |
| Foundation Fusion Solutions, LLC | $50.75 | 2022-2025 | |
| Penumbra, INC. | $38.55 | 2024 | Real Immersive System |
| Spr Therapeutics, INC | $33.62 | 2024 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $32.27 | 2020-2025 | Xtampza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $29.89 | 2023-2024 | Ztlido |
| Averitas Pharma INC. | $19.46 | 2025 | Qutenza |
| Biodelivery Sciences International, INC. | $16.78 | 2021 | |
| Abbvie INC. | $16.28 | 2023 | Botox |
| Vertex Pharmaceuticals Incorporated | $15.84 | 2025 | |
| Pacira Therapeutics, INC. | $15.00 | 2021 | |
| Grt US Holding, INC. | $12.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Siddiqi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.